554 related articles for article (PubMed ID: 26267219)
1. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
2. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Potter P; Maspero JF; Vermeulen J; Barkai L; Németh I; Baillieau RA; Garde JM; Giralt J; Doménech A; Izquierdo I; Nieto A
Pediatr Allergy Immunol; 2013 Mar; 24(2):144-50. PubMed ID: 23384091
[TBL] [Abstract][Full Text] [Related]
3. H1-antihistamines for chronic spontaneous urticaria.
Sharma M; Bennett C; Cohen SN; Carter B
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
Dakhale GN; Shinde AT; Mahatme MS; Hiware SK; Mishra DB; Mukhi JI; Salve AM
Int J Dermatol; 2014 May; 53(5):643-9. PubMed ID: 24320728
[TBL] [Abstract][Full Text] [Related]
6. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
Giménez-Arnau A; Izquierdo I; Maurer M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1088-91. PubMed ID: 19453774
[TBL] [Abstract][Full Text] [Related]
7. Safety of desloratadine syrup in children.
Bloom M; Staudinger H; Herron J
Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
[TBL] [Abstract][Full Text] [Related]
8. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of rupatadine in Japanese adult and adolescent patients with chronic spontaneous urticaria: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
Hide M; Suzuki T; Tanaka A; Aoki H
Allergol Int; 2019 Jan; 68(1):59-67. PubMed ID: 30029967
[TBL] [Abstract][Full Text] [Related]
10. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
Gimenez-Arnau A; Pujol RM; Ianosi S; Kaszuba A; Malbran A; Poop G; Donado E; Perez I; Izquierdo I; Arnaiz E;
Allergy; 2007 May; 62(5):539-46. PubMed ID: 17441794
[TBL] [Abstract][Full Text] [Related]
11. Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria.
Abajian M; Curto-Barredo L; Krause K; Santamaria E; Izquierdo I; Church MK; Maurer M; Giménez-Arnau A
Acta Derm Venereol; 2016 Jan; 96(1):56-9. PubMed ID: 26038847
[TBL] [Abstract][Full Text] [Related]
12. Levocetirizine and rupatadine in chronic idiopathic urticaria.
Johnson M; Kwatra G; Badyal DK; Thomas EA
Int J Dermatol; 2015 Oct; 54(10):1199-204. PubMed ID: 25521304
[TBL] [Abstract][Full Text] [Related]
13. Rupatadine in allergic rhinitis and chronic urticaria.
Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Bachert C; Maurer M
Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
[TBL] [Abstract][Full Text] [Related]
17. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
20. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E
Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
